Phase I/II Study of Spartalizumab (PDR001), An Anti-PD1 Mab, in Patients with Advanced Melanoma or Non-Small Cell Lung Cancer

Simple item page
dc.contributor.authorLin, C-C.
dc.contributor.authorTaylor, M.
dc.contributor.authorBoni, V.
dc.contributor.authorBrunsvig, P. F.
dc.contributor.authorGeater, S. L.
dc.contributor.authorSalvagni, S.
dc.contributor.authorGarrido Lopez, P.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorSriuranpong, V.
dc.contributor.authorPonce Aix, S.
dc.contributor.authorAscierto, P. A.
dc.contributor.authorFasolo, A.
dc.contributor.authorSezer, A.
dc.contributor.authorKowalski, D. M.
dc.contributor.authorFaris, J. E.
dc.contributor.authorCameron, S.
dc.contributor.authorMataraza, J.
dc.contributor.authorWu, H.
dc.contributor.authorAntona, V.
dc.contributor.authorOchoa de Olza, M.
dc.date.accessioned2023-04-18T11:07:16Z
dc.date.available2023-04-18T11:07:16Z
dc.date.issued2018
dc.identifier.endpage413en_US
dc.identifier.issn0923-7534en_US
dc.identifier.issueSupplement 8en_US
dc.identifier.startpage413en_US
dc.identifier.urihttp://hdl.handle.net/11727/8821
dc.identifier.volume29en_US
dc.identifier.wos000459277302338en_US
dc.language.isoengen_US
dc.relation.journalANNALS OF ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePhase I/II Study of Spartalizumab (PDR001), An Anti-PD1 Mab, in Patients with Advanced Melanoma or Non-Small Cell Lung Canceren_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine